Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 181 entries
View as:

Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01504581 Org: User:
Start: 03/31/11 End: - Due: -

Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01894399 Org: User:
Start: 09/30/13 End: 11/30/13 Due: 11/30/14

Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02081118 Org: User:
Start: 02/28/14 End: 04/30/15 Due: 04/30/16

A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01013064 Org: User:
Start: 11/30/09 End: 01/31/11 Due: 01/31/12

A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT06481098 Org: User:
Start: 05/28/24 End: 05/02/25 Due: 05/02/26

Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination

Phase: N/A Priority: Normal
NCT ID: NCT01651481 Org: User:
Start: 07/31/12 End: 12/31/12 Due: 12/31/13

A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01030315 Org: User:
Start: 10/31/09 End: 01/31/11 Due: 01/31/12

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00942344 Org: User:
Start: 05/31/07 End: 12/31/07 Due: 12/31/08

A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT05656092 Org: User:
Start: 03/06/23 End: 12/19/24 Due: 12/19/25

Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens

Phase: N/A Priority: Normal
NCT ID: NCT02418689 Org: User:
Start: 04/30/15 End: 04/30/21 Due: 04/30/22

Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02140489 Org: User:
Start: 02/28/14 End: 08/31/14 Due: 08/31/15

A Study of HM11260C in Healthy Male Subject

Phase: N/A Priority: Normal
NCT ID: NCT01093729 Org: User:
Start: 02/28/10 End: 10/31/10 Due: 10/31/11

Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01638286 Org: User:
Start: 08/31/12 End: 04/30/13 Due: 04/30/14

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg

Phase: N/A Priority: Normal
NCT ID: NCT02011633 Org: User:
Start: 10/31/13 End: 12/31/13 Due: 12/31/14

A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT04081844 Org: User:
Start: 05/03/18 End: 06/28/18 Due: 06/28/19

Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT01588145 Org: User:
Start: 03/31/12 End: 08/31/17 Due: 08/31/18

Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities

Phase: N/A Priority: Normal
NCT ID: NCT04167553 Org: User:
Start: 08/30/19 End: 12/09/20 Due: 12/09/21

Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501

Phase: N/A Priority: Normal
NCT ID: NCT03089112 Org: User:
Start: 03/31/17 End: 06/16/17 Due: 06/16/18

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05737082 Org: User:
Start: 03/30/23 End: 05/14/23 Due: 05/14/24

Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02941679 Org: User:
Start: 10/31/16 End: 04/30/18 Due: 04/30/19

Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05598151 Org: User:
Start: 01/11/23 End: 06/30/28 Due: 06/30/29

A Study to Evaluate the PK, Safety and Tolerability of HCP1803.

Phase: N/A Priority: Normal
NCT ID: NCT05723549 Org: User:
Start: 02/02/23 End: 03/20/23 Due: 03/20/24

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903

Phase: N/A Priority: Normal
NCT ID: NCT04762407 Org: User:
Start: 11/20/20 End: 02/24/21 Due: 02/24/22

Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02444819 Org: User:
Start: 03/31/15 End: 08/31/17 Due: 08/31/18

The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04764201 Org: User:
Start: 01/16/21 End: 03/08/21 Due: 03/08/22